Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Surgical excision followed by low dose rate radiotherapy in the management of resistant keloids.

World journal of plastic surgery

Mohammadi AA, Mohammadian Panah M, Pakyari MR, Tavakol R, Ahrary I, Seyed Jafari SM, Sharifian M.
PMID: 25489509
World J Plast Surg. 2013 Jun;2(2):81-6.

BACKGROUND: Depending on the cause, 40-90% of every deep dermis insult ends up in scar formation. Several modalities have been suggested as a treatment but a high rate of recurrence is reported in most of those interventions. High dose...

Cite
Mohammadi AA, Mohammadian Panah M, Pakyari MR, et al. Surgical excision followed by low dose rate radiotherapy in the management of resistant keloids. World J Plast Surg. 2013;2(2):81-6
Mohammadi, A. A., Mohammadian Panah, M., Pakyari, M. R., Tavakol, R., Ahrary, I., Seyed Jafari, S. M., & Sharifian, M. (2013). Surgical excision followed by low dose rate radiotherapy in the management of resistant keloids. World journal of plastic surgery, 2(2), 81-6.
Mohammadi, Ali Akbar, et al. "Surgical excision followed by low dose rate radiotherapy in the management of resistant keloids." World journal of plastic surgery vol. 2,2 (2013): 81-6.
Mohammadi AA, Mohammadian Panah M, Pakyari MR, Tavakol R, Ahrary I, Seyed Jafari SM, Sharifian M. Surgical excision followed by low dose rate radiotherapy in the management of resistant keloids. World J Plast Surg. 2013 Jun;2(2):81-6. PMID: 25489509; PMCID: PMC4238340.
Copy Download .nbib Format: NLM
A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.

Iranian Red Crescent medical journal

Ansari M, Omidvari S, Mosalaei A, Ahmadloo N, Mosleh-Shirazi MA, Mohammadianpanah M.
PMID: 22737461
Iran Red Crescent Med J. 2011 Mar;13(3):187-91. Epub 2011 Mar 01.

BACKGROUND: The combination of cisplatin and 5-fluorouracil (PF) is currently considered a standard and effective regimen for the treatment of advanced head and neck carcinomas. The aim of this study was to evaluate the efficacy and safety of docetaxel,...

Cite
Ansari M, Omidvari S, Mosalaei A, et al. A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. Iran Red Crescent Med J. 2011;13(3):187-91
Ansari, M., Omidvari, S., Mosalaei, A., Ahmadloo, N., Mosleh-Shirazi, M. A., & Mohammadianpanah, M. (2011). A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. Iranian Red Crescent medical journal, 13(3), 187-91.
Ansari, M, et al. "A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas." Iranian Red Crescent medical journal vol. 13,3 (2011): 187-91.
Ansari M, Omidvari S, Mosalaei A, Ahmadloo N, Mosleh-Shirazi MA, Mohammadianpanah M. A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. Iran Red Crescent Med J. 2011 Mar;13(3):187-91. Epub 2011 Mar 01. PMID: 22737461; PMCID: PMC3371950.
Copy Download .nbib Format: NLM
Paratesticular liposarcoma; a case report.

Iranian journal of cancer prevention

Omidvari S, Hamedi SH, Moaddab-Shoar L, Nasrollahi H, Daneshbod Y, Mosleh-Shirazi MA, Ansrai M, Mohammadianpanah M, Ahmadloo N, Mosalaei A.
PMID: 25628845
Iran J Cancer Prev. 2014;7(4):239-43.

Paratesticular sarcomas have happened rarely. Due to the infrequency of this malignant disease and its diverse histopathologic subtypes, no standard treatment would be available. Multiple treatments have reported in literature with different results. We have reported a 55 years...

Cite
Omidvari S, Hamedi SH, Moaddab-Shoar L, et al. Paratesticular liposarcoma; a case report. Iran J Cancer Prev. 2014;7(4):239-43
Omidvari, S., Hamedi, S. H., Moaddab-Shoar, L., Nasrollahi, H., Daneshbod, Y., Mosleh-Shirazi, M. A., Ansrai, M., Mohammadianpanah, M., Ahmadloo, N., & Mosalaei, A. (2014). Paratesticular liposarcoma; a case report. Iranian journal of cancer prevention, 7(4), 239-43.
Omidvari, Shapour, et al. "Paratesticular liposarcoma; a case report." Iranian journal of cancer prevention vol. 7,4 (2014): 239-43.
Omidvari S, Hamedi SH, Moaddab-Shoar L, Nasrollahi H, Daneshbod Y, Mosleh-Shirazi MA, Ansrai M, Mohammadianpanah M, Ahmadloo N, Mosalaei A. Paratesticular liposarcoma; a case report. Iran J Cancer Prev. 2014;7(4):239-43. PMID: 25628845; PMCID: PMC4307107.
Copy Download .nbib Format: NLM
A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province.

Iranian journal of medical sciences

Hosseini MA, Mohamadianpanah M, Zare-Bandeamiri M, Mosleh-Shirazi MA.
PMID: 29892149
Iran J Med Sci. 2018 May;43(3):313-317.

Hadron therapy (HT) with protons and carbon ions is an advanced radiotherapy technique. As the first report addressing this topic, the present study aimed to estimate the number of patients eligible for HT in Fars province and the whole...

Cite
Hosseini MA, Mohamadianpanah M, Zare-Bandeamiri M, et al. A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province. Iran J Med Sci. 2018;43(3):313-317
Hosseini, M. A., Mohamadianpanah, M., Zare-Bandeamiri, M., & Mosleh-Shirazi, M. A. (2018). A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province. Iranian journal of medical sciences, 43(3), 313-317.
Hosseini, Mohammad Amin, et al. "A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province." Iranian journal of medical sciences vol. 43,3 (2018): 313-317.
Hosseini MA, Mohamadianpanah M, Zare-Bandeamiri M, Mosleh-Shirazi MA. A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province. Iran J Med Sci. 2018 May;43(3):313-317. PMID: 29892149; PMCID: PMC5993909.
Copy Download .nbib Format: NLM
Pediatric glioblastoma multiforme: A single-institution experience.

Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Ansari M, Nasrolahi H, Kani AA, Mohammadianpanah M, Ahmadloo N, Omidvari S, Mosalaei A.
PMID: 23248421
Indian J Med Paediatr Oncol. 2012 Jul;33(3):155-60. doi: 10.4103/0971-5851.103142.

BACKGROUND: Glioblastoma multiforme (GBM) is the most common astrocytoma in adults and has a poor prognosis, with a median survival of about 12 months. But, it is rare in children. We report our experience on the pediatric population (20...

Cite
Ansari M, Nasrolahi H, Kani AA, et al. Pediatric glioblastoma multiforme: A single-institution experience. Indian J Med Paediatr Oncol. 2012;33(3):155-60doi: 10.4103/0971-5851.103142.
Ansari, M., Nasrolahi, H., Kani, A. A., Mohammadianpanah, M., Ahmadloo, N., Omidvari, S., & Mosalaei, A. (2012). Pediatric glioblastoma multiforme: A single-institution experience. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology, 33(3), 155-60. https://doi.org/10.4103/0971-5851.103142
Ansari, Mansour, et al. "Pediatric glioblastoma multiforme: A single-institution experience." Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology vol. 33,3 (2012): 155-60. doi: https://doi.org/10.4103/0971-5851.103142
Ansari M, Nasrolahi H, Kani AA, Mohammadianpanah M, Ahmadloo N, Omidvari S, Mosalaei A. Pediatric glioblastoma multiforme: A single-institution experience. Indian J Med Paediatr Oncol. 2012 Jul;33(3):155-60. doi: 10.4103/0971-5851.103142. PMID: 23248421; PMCID: PMC3523472.
Copy Download .nbib Format: NLM
Treatment results and prognostic indicators in thymic epithelial tumors: a clinicopathological analysis of 45 patients.

Iranian journal of medical sciences

Ansari M, Dehsara F, Mohammadianpanah M, Mosalaei A, Omidvari S, Ahmadloo N.
PMID: 25031486
Iran J Med Sci. 2014 Jul;39(4):341-9.

BACKGROUND: Thymomas are rare epithelial tumors arising from thymus gland. This study aims at investigating the clinical presentation, prognostic factors and treatment outcome of forty five patients with thymoma and thymic carcinoma.METHODS: Forty-five patients being histologically diagnosed with thymoma...

Cite
Ansari M, Dehsara F, Mohammadianpanah M, et al. Treatment results and prognostic indicators in thymic epithelial tumors: a clinicopathological analysis of 45 patients. Iran J Med Sci. 2014;39(4):341-9
Ansari, M., Dehsara, F., Mohammadianpanah, M., Mosalaei, A., Omidvari, S., & Ahmadloo, N. (2014). Treatment results and prognostic indicators in thymic epithelial tumors: a clinicopathological analysis of 45 patients. Iranian journal of medical sciences, 39(4), 341-9.
Ansari, Mansour, et al. "Treatment results and prognostic indicators in thymic epithelial tumors: a clinicopathological analysis of 45 patients." Iranian journal of medical sciences vol. 39,4 (2014): 341-9.
Ansari M, Dehsara F, Mohammadianpanah M, Mosalaei A, Omidvari S, Ahmadloo N. Treatment results and prognostic indicators in thymic epithelial tumors: a clinicopathological analysis of 45 patients. Iran J Med Sci. 2014 Jul;39(4):341-9. PMID: 25031486; PMCID: PMC4100045.
Copy Download .nbib Format: NLM
Very late relapse in breast cancer survivors: a report of 6 cases.

Iranian journal of cancer prevention

Omidvari S, Hamedi SH, Mohammadianpanah M, Nasrolahi H, Mosalaei A, Talei A, Ahmadloo N, Ansari M.
PMID: 25250120
Iran J Cancer Prev. 2013;6(2):113-7.

BACKGROUND: Breast cancer is the most common cancer and the leading cause of cancer death among the women worldwide. The risk of local and distant recurrence is the highest during the first two years following the initial treatment. Very...

Cite
Omidvari S, Hamedi SH, Mohammadianpanah M, et al. Very late relapse in breast cancer survivors: a report of 6 cases. Iran J Cancer Prev. 2013;6(2):113-7
Omidvari, S., Hamedi, S. H., Mohammadianpanah, M., Nasrolahi, H., Mosalaei, A., Talei, A., Ahmadloo, N., & Ansari, M. (2013). Very late relapse in breast cancer survivors: a report of 6 cases. Iranian journal of cancer prevention, 6(2), 113-7.
Omidvari, Shapour, et al. "Very late relapse in breast cancer survivors: a report of 6 cases." Iranian journal of cancer prevention vol. 6,2 (2013): 113-7.
Omidvari S, Hamedi SH, Mohammadianpanah M, Nasrolahi H, Mosalaei A, Talei A, Ahmadloo N, Ansari M. Very late relapse in breast cancer survivors: a report of 6 cases. Iran J Cancer Prev. 2013;6(2):113-7. PMID: 25250120; PMCID: PMC4142915.
Copy Download .nbib Format: NLM
Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma.

Asian Pacific journal of cancer prevention : APJCP

Nasrollahi H, Khaki S, Ansari M, Ahmadloo N, Khanjani N, Hamedi SH, Omidvari S, Mosalaei A, Mohammadianpanah M, Kadkhodaei B.
PMID: 34837931
Asian Pac J Cancer Prev. 2021 Nov 01;22(11):3711-3715. doi: 10.31557/APJCP.2021.22.11.3711.

BACKGROUND: Oral mucositis is a serious complication radiation therapy for cancer. This is a major complication during radiation therapy of the head and neck tumors in approximately all patients. Therefore, this study was conducted to evaluate the effect of...

Cite
Nasrollahi H, Khaki S, Ansari M, et al. Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2021;22(11):3711-3715doi: 10.31557/APJCP.2021.22.11.3711.
Nasrollahi, H., Khaki, S., Ansari, M., Ahmadloo, N., Khanjani, N., Hamedi, S. H., Omidvari, S., Mosalaei, A., Mohammadianpanah, M., & Kadkhodaei, B. (2021). Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma. Asian Pacific journal of cancer prevention : APJCP, 22(11), 3711-3715. https://doi.org/10.31557/APJCP.2021.22.11.3711
Nasrollahi, Hamid, et al. "Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma." Asian Pacific journal of cancer prevention : APJCP vol. 22,11 (2021): 3711-3715. doi: https://doi.org/10.31557/APJCP.2021.22.11.3711
Nasrollahi H, Khaki S, Ansari M, Ahmadloo N, Khanjani N, Hamedi SH, Omidvari S, Mosalaei A, Mohammadianpanah M, Kadkhodaei B. Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2021 Nov 01;22(11):3711-3715. doi: 10.31557/APJCP.2021.22.11.3711. PMID: 34837931.
Copy Download .nbib Format: NLM
Effect of Human Amniotic Membrane on Prevention of Colorectal Anastomosis Leakage in Cases with Neoadjuvant Radiotherapy: An Experimental Animal Study.

Iranian journal of medical sciences

Moslemi S, Joraghi SA, Roshanravan R, Ghahramani L, Mohammadianpanah M, Hosseinzadeh M, Rezaianzadeh A, Hussein AM, Najibpour N, Hosseini SV.
PMID: 27853330
Iran J Med Sci. 2016 Nov;41(6):501-506.

BACKGROUND: Radiotherapy is one of the most important factors which results in negative effects on wound healing and increases anastomosis leakage. Diverting loop ileostomy has been usually performed after colorectal anastomosis in cases of colorectal cancer with a history...

Cite
Moslemi S, Joraghi SA, Roshanravan R, et al. Effect of Human Amniotic Membrane on Prevention of Colorectal Anastomosis Leakage in Cases with Neoadjuvant Radiotherapy: An Experimental Animal Study. Iran J Med Sci. 2016;41(6):501-506
Moslemi, S., Joraghi, S. A., Roshanravan, R., Ghahramani, L., Mohammadianpanah, M., Hosseinzadeh, M., Rezaianzadeh, A., Hussein, A. M., Najibpour, N., & Hosseini, S. V. (2016). Effect of Human Amniotic Membrane on Prevention of Colorectal Anastomosis Leakage in Cases with Neoadjuvant Radiotherapy: An Experimental Animal Study. Iranian journal of medical sciences, 41(6), 501-506.
Moslemi, Sam, et al. "Effect of Human Amniotic Membrane on Prevention of Colorectal Anastomosis Leakage in Cases with Neoadjuvant Radiotherapy: An Experimental Animal Study." Iranian journal of medical sciences vol. 41,6 (2016): 501-506.
Moslemi S, Joraghi SA, Roshanravan R, Ghahramani L, Mohammadianpanah M, Hosseinzadeh M, Rezaianzadeh A, Hussein AM, Najibpour N, Hosseini SV. Effect of Human Amniotic Membrane on Prevention of Colorectal Anastomosis Leakage in Cases with Neoadjuvant Radiotherapy: An Experimental Animal Study. Iran J Med Sci. 2016 Nov;41(6):501-506. PMID: 27853330; PMCID: PMC5106565.
Copy Download .nbib Format: NLM
Applying Additive Hazards Models for Analyzing Survival in Patients with Colorectal Cancer in Fars Province, Southern Iran.

Asian Pacific journal of cancer prevention : APJCP

Madadizadeh F, Ghanbarnejad A, Ghavami V, Zare Bandamiri M, Mohammadianpanah M.
PMID: 28547944
Asian Pac J Cancer Prev. 2017 Apr 01;18(4):1077-1083. doi: 10.22034/APJCP.2017.18.4.1077.

Introduction: Colorectal cancer (CRC) is a commonly fatal cancer that ranks as third worldwide and third and the fifth in Iranian women and men, respectively. There are several methods for analyzing time to event data. Additive hazards regression models...

Cite
Madadizadeh F, Ghanbarnejad A, Ghavami V, et al. Applying Additive Hazards Models for Analyzing Survival in Patients with Colorectal Cancer in Fars Province, Southern Iran. Asian Pac J Cancer Prev. 2017;18(4):1077-1083doi: 10.22034/APJCP.2017.18.4.1077.
Madadizadeh, F., Ghanbarnejad, A., Ghavami, V., Zare Bandamiri, M., & Mohammadianpanah, M. (2017). Applying Additive Hazards Models for Analyzing Survival in Patients with Colorectal Cancer in Fars Province, Southern Iran. Asian Pacific journal of cancer prevention : APJCP, 18(4), 1077-1083. https://doi.org/10.22034/APJCP.2017.18.4.1077
Madadizadeh, Farzan, et al. "Applying Additive Hazards Models for Analyzing Survival in Patients with Colorectal Cancer in Fars Province, Southern Iran." Asian Pacific journal of cancer prevention : APJCP vol. 18,4 (2017): 1077-1083. doi: https://doi.org/10.22034/APJCP.2017.18.4.1077
Madadizadeh F, Ghanbarnejad A, Ghavami V, Zare Bandamiri M, Mohammadianpanah M. Applying Additive Hazards Models for Analyzing Survival in Patients with Colorectal Cancer in Fars Province, Southern Iran. Asian Pac J Cancer Prev. 2017 Apr 01;18(4):1077-1083. doi: 10.22034/APJCP.2017.18.4.1077. PMID: 28547944; PMCID: PMC5494219.
Copy Download .nbib Format: NLM
Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum.

Radiation oncology journal

Hosseini S, Bananzadeh AM, Mohammadianpanah M, Salek R, Taghizadeh-Kermani A.
PMID: 29506326
Radiat Oncol J. 2018 Mar;36(1):45-53. doi: 10.3857/roj.2017.00332. Epub 2018 Mar 05.

PURPOSE: Local recurrence is a common failure pattern in adenocarcinoma of the cecum. This study aimed to investigate the potential role of adjuvant radiation therapy on oncologic outcomes of patients with adenocarcinoma of the cecum.MATERIALS AND METHODS: This retrospective...

Cite
Hosseini S, Bananzadeh AM, Mohammadianpanah M, et al. Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum. Radiat Oncol J. 2018;36(1):45-53doi: 10.3857/roj.2017.00332.
Hosseini, S., Bananzadeh, A. M., Mohammadianpanah, M., Salek, R., & Taghizadeh-Kermani, A. (2018). Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum. Radiation oncology journal, 36(1), 45-53. https://doi.org/10.3857/roj.2017.00332
Hosseini, Sare, et al. "Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum." Radiation oncology journal vol. 36,1 (2018): 45-53. doi: https://doi.org/10.3857/roj.2017.00332
Hosseini S, Bananzadeh AM, Mohammadianpanah M, Salek R, Taghizadeh-Kermani A. Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum. Radiat Oncol J. 2018 Mar;36(1):45-53. doi: 10.3857/roj.2017.00332. Epub 2018 Mar 05. PMID: 29506326; PMCID: PMC5903363.
Copy Download .nbib Format: NLM
Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial.

Annals of coloproctology

Nasrolahi H, Mirzaei S, Mohammadianpanah M, Bananzadeh AM, Mokhtari M, Sasani MR, Mosalaei A, Omidvari S, Ansari M, Ahmadloo N, Hamedi SH, Khanjani N.
PMID: 31725999
Ann Coloproctol. 2019 Oct;35(5):242-248. doi: 10.3393/ac.2018.09.06. Epub 2019 Oct 31.

PURPOSE: Currently, neoadjuvant chemoradiation (CRT) followed by total mesorectal resection is considered the standard of care for treating locally advanced rectal cancer. This study aimed to investigate the efficacy and feasibility of adding induction chemotherapy to neoadjuvant CRT in...

Cite
Nasrolahi H, Mirzaei S, Mohammadianpanah M, et al. Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial. Ann Coloproctol. 2019;35(5):242-248doi: 10.3393/ac.2018.09.06.
Nasrolahi, H., Mirzaei, S., Mohammadianpanah, M., Bananzadeh, A. M., Mokhtari, M., Sasani, M. R., Mosalaei, A., Omidvari, S., Ansari, M., Ahmadloo, N., Hamedi, S. H., & Khanjani, N. (2019). Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial. Annals of coloproctology, 35(5), 242-248. https://doi.org/10.3393/ac.2018.09.06
Nasrolahi, Hamid, et al. "Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial." Annals of coloproctology vol. 35,5 (2019): 242-248. doi: https://doi.org/10.3393/ac.2018.09.06
Nasrolahi H, Mirzaei S, Mohammadianpanah M, Bananzadeh AM, Mokhtari M, Sasani MR, Mosalaei A, Omidvari S, Ansari M, Ahmadloo N, Hamedi SH, Khanjani N. Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial. Ann Coloproctol. 2019 Oct;35(5):242-248. doi: 10.3393/ac.2018.09.06. Epub 2019 Oct 31. PMID: 31725999; PMCID: PMC6863011.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries